Phase I single-dose trial of BL 1020 in volunteers.
Latest Information Update: 15 Feb 2007
At a glance
- Drugs BL 1020 (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors BioLineRx
- 15 Feb 2007 Status change
- 19 Apr 2006 New trial record.